Deutsche Bank’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $351K | Sell |
|
|||||
|
2025
Q1 | $513K | Sell |
|
|||||
|
2024
Q4 | $562K | Buy |
|
|||||
|
2024
Q3 | $372K | Buy |
|
|||||
|
2024
Q2 | $225K | Sell |
|
|||||
|
2024
Q1 | $188K | Buy |
|
|||||
|
2023
Q4 | $166K | Sell |
|
|||||
|
2023
Q3 | $141K | Buy |
|
|||||
|
2023
Q2 | $128K | Sell |
|
|||||
|
2023
Q1 | $218K | Buy |
|
|||||
|
2022
Q4 | $117K | Buy |
|
|||||
|
2022
Q3 | $94K | Sell |
|
|||||
|
2022
Q2 | $154K | Buy |
|
|||||
|
2022
Q1 | $130K | Sell |
|
|||||
|
2021
Q4 | $190K | Buy |
|
|||||
|
2021
Q3 | $198K | Sell |
|
|||||
|
2021
Q2 | $1.14M | Buy |
|
|||||
|
2021
Q1 | $175K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $400K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4K | Sell |
|
|||||
|
2019
Q3 | $22K | Sell |
|
|||||
|
2019
Q2 | $150K | Sell |
|
|||||
|
2019
Q1 | $468K | Buy |
|
|||||
|
2018
Q4 | $501K | Sell |
|
|||||
|
2018
Q3 | $1.54M | Buy |
|
|||||
|
2018
Q2 | $765K | Buy |
|
|||||
|
2018
Q1 | $324K | Sell |
|
|||||
|
2017
Q4 | $825K | Buy |
|
|||||
|
2017
Q3 | $811K | Sell |
|
|||||
|
2017
Q2 | $653K | Buy |
|
|||||
|
2017
Q1 | $436K | Buy |
|
|||||
|
2016
Q4 | $219K | Sell |
|
|||||
|
2016
Q3 | $690K | Buy |
|
|||||
|
2016
Q2 | $650K | Buy |
|
|||||
|
2016
Q1 | $358K | Sell |
|
|||||
|
2015
Q4 | $816K | Buy |
|
|||||
|
2015
Q3 | $927K | Buy |
|
|||||
|
2015
Q2 | $510K | Buy |
|
|||||
|
2015
Q1 | $738K | Sell |
|
|||||
|
2014
Q4 | $1.42M | Buy |
|
|||||
|
2014
Q3 | $974K | Sell |
|
|||||
|
2014
Q2 | $695K | Sell |
|
|||||
|
2014
Q1 | $1.45M | Buy |
|
|||||
|
2013
Q4 | $412K | Buy |
|
|||||
|
2013
Q3 | $319K | Buy |
|